The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Holter monitor cardiac safety evaluation of vincristine sulfate liposomes injection (VSLI) administered to humans with active cancer.
T. Sato
No relevant relationships to disclose
A. Y. Bedikian
No relevant relationships to disclose
J. A. Glaspy
No relevant relationships to disclose
R. Gonzalez
No relevant relationships to disclose
L. Prasad
Employment or Leadership Position - Talon Therapeutics
Stock Ownership - Talon Therapeutics
G. L. Messerschmidt
Employment or Leadership Position - Talon Therapeutics
Stock Ownership - Talon Therapeutics
J. Silverman
Employment or Leadership Position - Talon Therapeutics
Stock Ownership - Talon Therapeutics
S. R. Deitcher
Employment or Leadership Position - Talon Therapeutics
Stock Ownership - Talon Therapeutics